Log In
Print this Print this

IV finafloxacin

  Manage Alerts
Collapse Summary General Information
Company MerLion Pharmaceuticals Pte. Ltd.
DescriptionIV formulation of a pH activated fluoroquinolone antibiotic
Molecular Target DNA gyrase ; Topoisomerase
Mechanism of ActionProkaryotic replication inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today